A phase I study of bortezomib and temozolomide in patients with advanced solid tumors

被引：0
作者：
J. Portnow
P. Frankel
S. Koehler
P. Twardowski
S. Shibata
C. Martel
R. Morgan
M. Cristea
W. Chow
D. Lim
V. Chung
K. Reckamp
L. Leong
T. W. Synold
机构：
[1] City of Hope,Department of Medical Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Bortezomib; Temozolomide; Phase I; Pharmacokinetics; Hepatic enzyme-inducing anticonvulsants;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：505 / 514
页数：9
相关论文
共 50 条
  • [31] Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors
    Alan H. Bryce
    Ravi Rao
    Jann Sarkaria
    Joel M. Reid
    Yingwei Qi
    Rui Qin
    C. David James
    Robert B. Jenkins
    Joseph Boni
    Charles Erlichman
    Paul Haluska
    [J]. Investigational New Drugs, 2012, 30 : 1934 - 1941
  • [32] Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors
    Bryce, Alan H.
    Rao, Ravi
    Sarkaria, Jann
    Reid, Joel M.
    Qi, Yingwei
    Qin, Rui
    James, C. David
    Jenkins, Robert B.
    Boni, Joseph
    Erlichman, Charles
    Haluska, Paul
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (05) : 1934 - 1941
  • [33] Phase I study of temozolomide in paediatric patients with advanced cancer
    Estlin, EJ
    Lashford, L
    Ablett, S
    Price, L
    Gowing, R
    Gholkar, A
    Kohler, J
    Lewis, IJ
    Morland, B
    Pinkerton, CR
    Stevens, R
    Mott, M
    Stevens, R
    Newell, DR
    Walker, D
    Dicks-Mireaux, C
    McDowell, H
    Reidenberg, P
    Statkevich, P
    Marco, A
    Batra, V
    Dugan, N
    Pearson, ADJ
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (05) : 652 - 661
  • [34] A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors
    Christos E. Kyriakopoulos
    Amy M. Braden
    Jill M. Kolesar
    Jens C. Eickhoff
    Howard H. Bailey
    Jennifer Heideman
    Glenn Liu
    Kari B. Wisinski
    [J]. Investigational New Drugs, 2017, 35 : 290 - 297
  • [35] A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
    William R. Schelman
    Sherry Morgan-Meadows
    Rebecca Marnocha
    Fred Lee
    Jens Eickhoff
    Wei Huang
    Marcia Pomplun
    Zhisheng Jiang
    Dona Alberti
    Jill M. Kolesar
    Percy Ivy
    George Wilding
    Anne M. Traynor
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 63 : 1147 - 1156
  • [36] A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors
    Kyriakopoulos, Christos E.
    Braden, Amy M.
    Kolesar, Jill M.
    Eickhoff, Jens C.
    Bailey, Howard H.
    Heideman, Jennifer
    Liu, Glenn
    Wisinski, Kari B.
    [J]. INVESTIGATIONAL NEW DRUGS, 2017, 35 (03) : 290 - 297
  • [37] A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
    Schelman, William R.
    Morgan-Meadows, Sherry
    Marnocha, Rebecca
    Lee, Fred
    Eickhoff, Jens
    Huang, Wei
    Pomplun, Marcia
    Jiang, Zhisheng
    Alberti, Dona
    Kolesar, Jill M.
    Ivy, Percy
    Wilding, George
    Traynor, Anne M.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1147 - 1156
  • [38] Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors
    Jennifer R. Eads
    Smitha S. Krishnamurthi
    Joel Saltzman
    Joseph A. Bokar
    Panos Savvides
    Neal J. Meropol
    Joseph Gibbons
    Henry Koon
    Neelesh Sharma
    Lisa Rogers
    John J. Pink
    Yan Xu
    Jan H. Beumer
    John Riendeau
    Pingfu Fu
    Stanton L. Gerson
    Afshin Dowlati
    [J]. Investigational New Drugs, 2021, 39 : 142 - 151
  • [39] Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors
    Eads, Jennifer R.
    Krishnamurthi, Smitha S.
    Saltzman, Joel
    Bokar, Joseph A.
    Savvides, Panos
    Meropol, Neal J.
    Gibbons, Joseph
    Koon, Henry
    Sharma, Neelesh
    Rogers, Lisa
    Pink, John J.
    Xu, Yan
    Beumer, Jan H.
    Riendeau, John
    Fu, Pingfu
    Gerson, Stanton L.
    Dowlati, Afshin
    [J]. INVESTIGATIONAL NEW DRUGS, 2021, 39 (01) : 142 - 151
  • [40] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Iqbal, Syma
    Lenz, Heinz-Josef
    Gandara, David R.
    Shibata, Stephen I.
    Groshen, Susan
    Synold, Timothy W.
    Newman, Edward M.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 85 - 91
12345